BIOMAT Database Logo BIOMAT Database Logo

Renal allograft survival in patients with positive donor-specific B lymphocyte crossmatches. 1987

H J Noreen, and E van der Hagen, and F H Bach, and D Fryd, and N Ascher, and R L Simmons, and J S Najarian
Department of Laboratory Medicine, University of Minnesota, Minneapolis.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

H J Noreen, and E van der Hagen, and F H Bach, and D Fryd, and N Ascher, and R L Simmons, and J S Najarian
Outcome of donor specific transfusion renal transplants across B cell positive crossmatches.
February 1989, Transplantation proceedings,
H J Noreen, and E van der Hagen, and F H Bach, and D Fryd, and N Ascher, and R L Simmons, and J S Najarian
Renal allograft survival in patients with positive B cell crossmatch to their donor.
January 1984, Annals of surgery,
H J Noreen, and E van der Hagen, and F H Bach, and D Fryd, and N Ascher, and R L Simmons, and J S Najarian
Improved survival and function of renal transplants with positive B cell crossmatches.
May 1979, Transplantation,
H J Noreen, and E van der Hagen, and F H Bach, and D Fryd, and N Ascher, and R L Simmons, and J S Najarian
Relevance of "remote positive" crossmatches and positive B-cell crossmatches in renal transplantation.
August 1990, Transplantation proceedings,
H J Noreen, and E van der Hagen, and F H Bach, and D Fryd, and N Ascher, and R L Simmons, and J S Najarian
Donor-specific preformed B-lymphocyte antibodies and mixed lymphocyte culture (MLC) blocking in cadaver renal allograft recipients.
June 1978, Transplantation proceedings,
H J Noreen, and E van der Hagen, and F H Bach, and D Fryd, and N Ascher, and R L Simmons, and J S Najarian
Luminex donor-specific crossmatches.
June 2008, Tissue antigens,
H J Noreen, and E van der Hagen, and F H Bach, and D Fryd, and N Ascher, and R L Simmons, and J S Najarian
Donor-specific antibodies. Clinical relevance of antibodies detected in lymphocyte crossmatches.
September 1991, Clinics in laboratory medicine,
H J Noreen, and E van der Hagen, and F H Bach, and D Fryd, and N Ascher, and R L Simmons, and J S Najarian
Renal transplantation in patients with pretransplant donor-specific antibodies and negative flow cytometry crossmatches.
March 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
H J Noreen, and E van der Hagen, and F H Bach, and D Fryd, and N Ascher, and R L Simmons, and J S Najarian
Donor specific CDC lymphocyte crossmatch and five year allograft survival.
November 1998, Transplantation proceedings,
H J Noreen, and E van der Hagen, and F H Bach, and D Fryd, and N Ascher, and R L Simmons, and J S Najarian
Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches.
October 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Copied contents to your clipboard!